A promising molecular target for liver cancer therapy
Key points
- Although GABA and GABA receptors function as an inhibitory neurotransmitter in the mature CNS, abnormal levels of gene and protein expression of some GABA receptor subunits have been detected in many malignant tumors, such as π subunit in pancreatic cancer.
- A research to be published in the World Journal of Gastroenterology on December 21,2008 addresses a new finding about this hotpoint.
- In this way, they identified the overexpression of GABA receptor α3 subunit (GABRA3) in HCC cells.
- They also determined the in vitro and in vivo effect of GABA on the proliferation of GABRA3-positive cell lines, and found that GABA increased HCC growth in a dose-dependent manner.
Although GABA and GABA receptors function as an inhibitory neurotransmitter in the mature CNS, abnormal levels of gene and protein expression of some GABA receptor subunits have been detected in many malignant tumors, such as π subunit in pancreatic cancer. This indicates that GABAergic system may play an important role in the pathogenesis and development of malignant tumors, and their expression levels are important for prognosis.
A research to be published in the World Journal of Gastroenterology on December 21,2008 addresses a new finding about this hotpoint. The research team led by Prof. Li from Cancer Institute of Central South University used in silico databases to identify genes that were overexpressed in HCC.
In this way, they identified the overexpression of GABA receptor α3 subunit (GABRA3) in HCC cells. Knockdown of endogenous GABRA3 expression in HepG2 attenuated HCC cell growth, suggesting its role in HCC cell viability.
They also determined the in vitro and in vivo effect of GABA on the proliferation of GABRA3-positive cell lines, and found that GABA increased HCC growth in a dose-dependent manner.
Notably, the addition of GABA into the cell culture medium promoted the proliferation of GABRA3-expressing HepG2 cells, but not GABRA3-knockdown HepG2 cells. That means GABA stimulates HepG2 cell growth through GABRA3.
These findings highlight the importance of elucidating the role GABAergic activity play in the pathogenesis of HCC. GABA and GABRA3 could play important roles in HCC development and progression and can be a promising molecular target for the development of new diagnostic and therapeutic strategies for HCC.
###
Reference - - Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor ?3 subunit. World J Gastroenterol 2008;14(47) - - 7175-7182
Contact - - Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Correspondence to - - Guan-Cheng Li, MD, PhD, Tumor Immunobiology Laboratory of Cancer Research Institute, Central South University, Changsha 410078, Hunan Province, China. libsun@163.com
Telephone - - +86-731-4805445
Fax - - +86-731-2355042
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsHot on the trail of the hepatitis-liver cancer connection
Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors…
31 January 2015
NewsUseful markers to predict response to chemotherapy in patients with liver cancer
A study led by the researcher at the Institute of Biomedical Research (IDIBELL), Isabel Fabregat, could serve to select patients with hepatocellular carcinoma unresponsive to most frequently used drug in liver cancer:…
24 October 2014
NewsPTPRZ-MET fusion protein: A new target for personalized brain cancer treatment
Researchers at the University of California, San Diego School of Medicine have identified a new fusion protein found in approximately 15 percent of secondary glioblastomas or brain tumors. The finding offers new…
